U.S. Markets close in 41 mins

Altria shares fall after FDA's Gottlieb describes 'difficult' meeting on Juul

Kate Rooney

Shares of Altria MO dropped 2 percent in a sudden move after Food and Drug Administration Commissioner Scott Gottlieb said a meeting last week with the company and its e-cigarette unit Juul was "difficult."

Gottlieb said he did not come away with any evidence that public health concerns drove Altria's decision to invest in Juul, and instead says it looks like a business decision. 

Altria made a $12.8 billion investment in the e-cigarette maker late last year. In September, Gottlieb ordered the five largest e-cigarette manufacturers, including Juul and Altria, to submit plans outlining how they planned to curb youth use of e-cigarettes, also known as "vaping." 

The FDA commissioner has accused Juul and Marlboro-maker Altria executives of reneging on promises they made to help combat teen vaping. Juul declined to comment on the FDA meeting but did say it happened last Wednesday. 

—This is a developing story. Check back for updates.



More From CNBC

  • Here's Why Shares of Uxin Climbed Higher on Thursday
    Business
    Motley Fool

    Here's Why Shares of Uxin Climbed Higher on Thursday

    Chinese online used-car dealer Uxin's (NASDAQ: UXIN) volatile week continued on Thursday, with shares up more than 11% as the market continues to digest, and at least for now dismiss, a critical short-seller report that temporarily sent shares crashing. Shares of Uxin lost more than half of their value midday Tuesday after J Capital Research analyst Anne Stevenson-Yang issued a report claiming that Uxin has exaggerated the volume of auto sales it processes by as much as 40%, and that founder and CEO Kun Dai was making false statements about the business' strength while taking cash out of the business. The response helped Uxin shares to recover much of what they lost on Wednesday.

  • Here's Why StoneCo Stock Is Plunging Today
    Business
    Motley Fool

    Here's Why StoneCo Stock Is Plunging Today

    Shares of Brazilian fintech company StoneCo (NASDAQ: STNE), which gained notoriety in recent months after being added to Berkshire Hathaway's portfolio, are plummeting today. Generally speaking, moves like this are often seen after earnings announcements, but StoneCo isn't set to report earnings again for another couple months. In this case, the plunge appears to be triggered by a move from a rival company.

  • Snap Stock Downgraded Twice in 1 Day: What You Need to Know
    Business
    Motley Fool

    Snap Stock Downgraded Twice in 1 Day: What You Need to Know

    Wedbush thinks this expectation is already factored into Snap's higher share price, and therefore rates the stock only neutral, with a $12.25 price target. Downgrading Snap stock, part deux Vertical Group is even more pessimistic, observing in a note covered by StreetInsider.com (subscription required) that Snap is experiencing "stagnant" return on its investments, and cutting spending (because without returns, what's the point? in order to conserve cash.

  • Boeing 'shielded' from 737 Max order cancellations
    Business
    MarketWatch

    Boeing 'shielded' from 737 Max order cancellations

    Don't expect Boeing Co. to face a slew of order cancellations following the 737 Max debacle. Airlines, Boeing's (BA) main customers, are hungry for fuel-efficient single-aisle aircraft such as the Max, and there's a long backlog for the jet's closest competitor, Airbus SE' (FR:AIR) A320neo, analysts at Oxford Economics said in a note Thursday. “That will shield Boeing from a mass cancellation of orders,” the analysts said.

  • Canopy Growth strikes $3.4B deal to buy Acreage
    Business
    Yahoo Finance Video

    Canopy Growth strikes $3.4B deal to buy Acreage

    Canopy Growth stock is up today on news that it's made a deal to buy Acreage Holdings. Yahoo Finance's Zack Guzman and Kristin Myers are joined by Lauren Smith Brody, 'The Fifth Trimester' author and founder, to discuss.

  • Here's Why Blackstone Shares Jumped on Thursday
    Business
    Motley Fool

    Here's Why Blackstone Shares Jumped on Thursday

    Shares of Blackstone Group (NYSE: BX) climbed nearly 7% on Thursday morning after the alternative asset manager reported first-quarter earnings that blew past expectations and announced plans to convert to a corporation from a partnership. Blackstone, before markets opened, said it had earned $0.71 per share in the first quarter, easily surpassing the consensus estimate for $0.53 per share in earnings. The partnership structure has prevented some classes of investors, namely pension funds and other tax-exempt institutions, from buying shares of Blackstone, and has made the company ineligible for inclusion on certain indexes.

  • Why Nintendo Stock Popped Today
    Business
    Motley Fool

    Why Nintendo Stock Popped Today

    What happened Shares of Nintendo (NASDAQOTH: NTDOY) were up 13.6% as of 1:30 p.m. EDT Thursday after news emerged that the company's Switch gaming console will soon begin selling in China. But Nintendo won't be selling the devices directly.

  • Can You Imagine How Associated Banc-Corp's (NYSE:ASB) Shareholders Feel About The 27% Share Price Increase?
    Business
    Simply Wall St.

    Can You Imagine How Associated Banc-Corp's (NYSE:ASB) Shareholders Feel About The 27% Share Price Increase?

    Furthermore, you'd generally like to see the share price rise faster than the market But Associated Banc-Corp (NYSE:ASB) has fallen short of that second goal, with a share price rise of 27% over five years, which is below the market return. One flawed but reasonable way to assess how sentiment around a company has changed is to compare the earnings per share (EPS) with the share price. During five years of share price growth, Associated Banc-Corp achieved compound earnings per share (EPS) growth of 12% per year.

  • Skechers Stocks Plummets as Q1 Results Don't Meet Expectations
    Business
    Market Realist

    Skechers Stocks Plummets as Q1 Results Don't Meet Expectations

    Skechers Stocks Plummets as Q1 Results Don't Meet ExpectationsSkechers's Q1 results disappoint Skechers stock was down 10.5% as of 1:32 pm ET today as the company missed analysts' sales and earnings estimates for the first quarter of 2019.

  • Is Aphria a Buy on the Dip?
    Business
    Motley Fool

    Is Aphria a Buy on the Dip?

    Shares of Aphria (NYSE: APHA) have tumbled about 16% since the company reported earnings results for its fiscal third quarter. This was the first full quarter since the company and its peers began selling adult-use recreational marijuana in Canada, and investors enthusiastic about the future are wondering if the market has overreacted and created a bargain opportunity. Let's take a closer look at the road ahead of Aphria to see if this troubled marijuana stock is a buy right now.

  • Is Zynga Poised for Significant Growth in 2019 and Beyond?
    Business
    Market Realist

    Is Zynga Poised for Significant Growth in 2019 and Beyond?

    These Tech Stocks Could Be Overvalued at Their Current Prices(Continued from Prior Part)ZNGA's returns The stock of gaming company Zynga (ZNGA) has generated a return of 51% in the last 12 months. Since the start of 2019, the stock is up 36%.

  • How Financially Strong Is Hologic, Inc. (NASDAQ:HOLX)?
    Business
    Simply Wall St.

    How Financially Strong Is Hologic, Inc. (NASDAQ:HOLX)?

    Hologic, Inc. (NASDAQ:HOLX), a large-cap worth US$13b, comes to mind for investors seeking a strong and reliable stock investment. This article will examine Hologic's financial liquidity and debt levels to get an idea of whether the company can deal with cyclical downturns and maintain funds to accommodate strategic spending for future growth. HOLX's debt levels have fallen from US$3.4b to US$3.1b over the last 12 months , which also accounts for long term debt.

  • Harry Boxer: Two marijuana stocks are among charts worth watching
    Business
    MarketWatch

    Harry Boxer: Two marijuana stocks are among charts worth watching

    Marijuana stocks are among our top charts to watch today. Bank of America Merrill Lynch named the company as one of three marijuana stocks to buy. The stock, after sharp year-to-date gains, has been consolidating in recent weeks, but may be on the verge of its next leg up with cannabis stocks in general.

  • How Much Of Waste Connections, Inc. (NYSE:WCN) Do Institutions Own?
    Business
    Simply Wall St.

    How Much Of Waste Connections, Inc. (NYSE:WCN) Do Institutions Own?

    If you want to know who really controls Waste Connections, Inc. (NYSE:WCN), then you'll have to look at the makeup of its share registry. Insiders often own a large chunk of younger, smaller, companies while huge companies tend to have institutions as shareholders. Companies that have been privatized tend to have low insider ownership.

  • Why Mustang Bio Stock Is On Fire Today
    News
    Motley Fool

    Why Mustang Bio Stock Is On Fire Today

    Mustang's shares are blasting off in response to the news that an experimental gene therapy, MB-107, for "bubble boy" disease -- also known as X-linked severe combined immunodeficiency, or XSCID for short -- reportedly cured eight boys with the deadly condition. Equally critical, Mustang said that the boys are showing no signs of unintended side effects from the therapy -- an issue that has derailed prior gene therapies for XSCID. Mustang licensed MB-107 from St. Jude Children's Research Hospital.

  • Business
    Barrons.com

    GE Stock Got a Thumbs Up From a Mysterious 'Smartest Man'

    GE)'s beaten-down stock is up 25% year to date, and Melius Research analyst Scott Davis says the smartest industrial investor he knows is buying the shares. That's a tantalizing statement. Who is this investing star?

  • Why Check Point Software Stock Dropped 8% Today
    Business
    Motley Fool

    Why Check Point Software Stock Dropped 8% Today

    Shares of IT security specialist Check Point Software Technologies (NASDAQ: CHKP) plunged more than 11% in early trading on the Nasdaq today before retracing to about an 8.2% loss as of 12:40 p.m. EDT. Check Point reported its fiscal first-quarter 2019 earnings this morning, but earnings weren't the problem this time -- guidance was. An earnings beat could have sent Check Point stock up today.

  • Nasdaq President says watch out for these IPOs in 2019
    Business
    Yahoo Finance Video

    Nasdaq President says watch out for these IPOs in 2019

    Nasdaq President Nelson Griggs joins Yahoo Finance's Julie Hyman and Adam Shapiro to talk about the 2019 IPO rush and what we can expect for the rest of the year.

  • Here's Why Amyris Is Soaring Today
    Business
    Motley Fool

    Here's Why Amyris Is Soaring Today

    What happened Shares of Amyris (NASDAQ: AMRS) jumped nearly 23% today after the company announced the preliminary details of a long-awaited financial transaction with a major technology licensee and shareholder. The synthetic biology pioneer's technology is used to manufacture a key chemical precursor to vitamin E, which allowed it to receive royalties from DSM (a Dutch multinational active in the fields of health, nutrition, and materials) on vitamin E sales. The pair have agreed to simplify the arrangement.

  • Why Tandem Diabetes Care Stock Sank Today
    Business
    Motley Fool

    Why Tandem Diabetes Care Stock Sank Today

    What happened Shares of Tandem Diabetes Care (NASDAQ: TNDM) closed down 9.9% on Wednesday after sinking as much as 11.9% earlier in the day. There wasn't any negative news specific to the insulin pump maker. However, healthcare stocks overall took a beating on Wednesday amid increasing concerns about the political climate in Washington D.C., particularly with the Medicare for All plan proposed by presidential candidate Sen. Bernie Sanders (I-VT).

  • Cover story: Joseph Kim's art of the bio-deal
    Business
    American City Business Journals

    Cover story: Joseph Kim's art of the bio-deal

    While many biopharmaceutical companies have partnerships or collaborations with one or two larger companies, Inovio Pharmaceuticals has product development deals in place with more than a half dozen pharmaceutical and biotech firms and research organizations inside and outside the United States.  Inovio is in that position largely because it is developing a technology platform with two parts that can be applied to a variety of medical conditions. The second part is the system for delivering the therapy through the skin or into muscle tissues using brief and low voltage electronic pulses.   That standing, said Inovio co-founder and CEO J. Joseph Kim, gives the Plymouth Meeting-based company different aspirations than other development-stage drug developers.

  • Amazon Prime Could Be Peaking in the US
    Business
    Motley Fool

    Amazon Prime Could Be Peaking in the US

    Exactly a year ago today, e-commerce juggernaut Amazon.com (NASDAQ: AMZN) confirmed that its global Prime member base had "exceeded 100 million." That was a rare disclosure from a company known for playing important operating metrics close to the vest. Amazon did not provide a geographical breakdown of the member base, which would be necessary to figure out just how much the company brings in from Prime membership fees since prices vary wildly by market. Consumer Intelligence Research Partners (CIRP) released a research report yesterday that points to slowing growth in Amazon Prime membership in the U.S. There were an estimated 103 million U.S. Prime members at the end of the first quarter, and they spend an average of $1,400 per year, according to the report.

  • Pier 1 liquidation is a possibility, analysts say
    Business
    MarketWatch

    Pier 1 liquidation is a possibility, analysts say

    Pier 1 Imports Inc.'s Interim Chief Executive Cheryl Bachelder may have taken an optimistic tone after the home décor retailer reported disappointing fourth-quarter earnings, but analysts were bearish, bringing up the possibility of a liquidation in the not-so-distant future. “Given the trends in business, and its negative earnings per share, EBITDA [earnings before interest, tax, depreciation and amortization], and free cash flow, we see Pier 1 and its $1.6 billion in revenues as potentially at risk of needing liquidation if trends don't improve,” wrote KeyBanc Capital Markets analysts led by Bradley Thomas. KeyBanc thinks Kirkland's Inc. (KIRK)  , Williams-Sonoma Inc. (WSM)  , Bed Bath & Beyond Inc. (BBBY)  and At Home Group Inc. (HOME)  would benefit from a Pier 1 (PIR)  liquidation.

  • Why Century Aluminum Stock Dropped Today
    Business
    Motley Fool

    Why Century Aluminum Stock Dropped Today

    But here's the thing: While this is "earnings season," a time of year we've been trained to expect to see big rises (and falls) in our stocks, Century Aluminum hasn't reported earnings yet. In fact, it's not expected to report earnings until April 30. Unfortunately, while Century hasn't yet reported, Alcoa (NYSE: AA) just did -- and it seems that Alcoa's bad news is turning out to be even worse news for Century.

  • A Look At The Intrinsic Value Of Stitch Fix, Inc. (NASDAQ:SFIX)
    Business
    Simply Wall St.

    A Look At The Intrinsic Value Of Stitch Fix, Inc. (NASDAQ:SFIX)

    Today we will run through one way of estimating the intrinsic value of Stitch Fix, Inc. (NASDAQ:SFIX) by taking the expected future cash flows and discounting them to their present value. We generally believe that a company's value is the present value of all of the cash it will generate in the future. Anyone interested in learning a bit more about intrinsic value should have a read of the Simply Wall St analysis model.